lamifiban has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arbeille, B; Fauvel-Lafeve, F; Gomes, N; Lebos, C; Legrand, C; Vassy, J | 1 |
1 other study(ies) available for lamifiban and Adenocarcinoma
Article | Year |
---|---|
Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists.
Topics: Abciximab; Acetates; Adenocarcinoma; Antibodies, Monoclonal; Blood Platelets; Blood Vessels; Breast Neoplasms; Cell Adhesion; Endothelium, Vascular; Extracellular Matrix; Female; Humans; Immunoglobulin Fab Fragments; Integrin alphaVbeta3; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Receptors, Vitronectin; Regional Blood Flow; Tumor Cells, Cultured; Tyrosine | 2004 |